Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04386811 · ClinicalTrials.gov registry record · Phase 1
Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Tele-health Study of Stimulant-induced Improvement in Neurocognitive Functioning.
A Phase 1 study, sponsored by Yale University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT04386811 is a Phase 1 study that was terminated before completion, run by Yale University. The registered enrollment target is 3 participants.
The verdict
NCT04386811, a Phase 1 study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to assess vitamin D as a therapeutic adjunct in the stimulant treatment of ADHD.
Interventions
- OTHER Placebo
- DRUG Calcitriol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-08-05 |
| Est. Completion | 2020-09-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04386811
The ClinicalTrials.gov registry entry for NCT04386811 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04386811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04386811 about?
NCT04386811 is a clinical study titled "Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Tele-health Study of Stimulant-induced Improvement in Neurocognitive Functioning.". The purpose of this study is to assess vitamin D as a therapeutic adjunct in the stimulant treatment of ADHD.
What is the current status of trial NCT04386811?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2020-08-05. Estimated completion is 2020-09-29.
What interventions are being tested in trial NCT04386811?
The interventions under investigation include: Placebo (OTHER), Calcitriol (DRUG).
Who is sponsoring clinical trial NCT04386811?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.